Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| Market is closed on Sun. Jan. 14, 2024 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting REGN price | REGN will advance at least -0% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |